{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:17:57Z","timestamp":1788175077868,"version":"build-2803163510"},"reference-count":86,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.drudis.2018.11.010","type":"journal-article","created":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T12:30:16Z","timestamp":1542630616000},"page":"440-451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["A review of non-invasive insulin delivery systems for diabetes therapy in clinical trials over the past decade"],"prefix":"10.1016","volume":"24","author":[{"given":"Najma","family":"Easa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raid G.","family":"Alany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Carew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Vangala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2018.11.010_bib0005","series-title":"Global Report on Diabetes","author":"WHO","year":"2016"},{"key":"10.1016\/j.drudis.2018.11.010_bib0010","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.drudis.2018.11.010_bib0015","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diabres.2011.10.029","article-title":"IDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2011 and 2030","volume":"94","author":"Whiting","year":"2011","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.drudis.2018.11.010_bib0020","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045","volume":"138","author":"Cho","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.drudis.2018.11.010_bib0025","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1177\/1932296814555820","article-title":"Afrezza Inhaled Insulin","volume":"8","author":"Klonoff","year":"2014","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.drudis.2018.11.010_bib0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.coph.2017.07.011","article-title":"Buccal delivery of small molecules and biologics: of mucoadhesive polymers, films, and nanoparticles","volume":"36","author":"Morales","year":"2017","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.drudis.2018.11.010_bib0035","series-title":"Insulin Interventional Studies Diabetes","author":"U.S. National Library of Medicine","year":"2017"},{"key":"10.1016\/j.drudis.2018.11.010_bib0040","series-title":"Insulin: Molecular Biology to Pathology.","first-page":"64","article-title":"Insulin synthesis","author":"Ashcroft","year":"1992"},{"key":"10.1016\/j.drudis.2018.11.010_bib0045","series-title":"Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications","author":"WHO","year":"1999"},{"key":"10.1016\/j.drudis.2018.11.010_bib0050","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"The Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.drudis.2018.11.010_bib0055","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-3476(94)70190-3","article-title":"Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial","volume":"125","author":"The Diabetes Control and Complications Trial Research Group","year":"1994","journal-title":"J. Pediatr."},{"key":"10.1016\/j.drudis.2018.11.010_bib0060","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM200002103420603","article-title":"Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy","volume":"342","author":"Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Research Group","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drudis.2018.11.010_bib0065","first-page":"251","article-title":"The internal secretion of the pancreas","volume":"7","author":"Banting","year":"1922","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.drudis.2018.11.010_bib0070","first-page":"72","article-title":"Manufacturing Pharmaceuticals: Eli Lilly and Company, 1876\u20131948","volume":"18","author":"Madison","year":"1989","journal-title":"Bus. Econ. Hist."},{"key":"10.1016\/j.drudis.2018.11.010_bib0075","series-title":"Innovation and Inequality:Emerging Technologies in an Unequal World","first-page":"67","article-title":"Uneven publics: life, death, and recombinant insulin","author":"Gatchair","year":"2014"},{"key":"10.1016\/j.drudis.2018.11.010_bib0080","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2337\/diab.43.3.396","article-title":"Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin","volume":"43","author":"Howey","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.drudis.2018.11.010_bib0085","series-title":"Pharmaceutical Biotechnology: Fundamentals and Applications","first-page":"265","article-title":"Insulin","author":"Crommelin","year":"2007"},{"key":"10.1016\/j.drudis.2018.11.010_bib0090","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1177\/193229680800200325","article-title":"The failure of exubera: are we beating a dead horse?","volume":"2","author":"Heinemann","year":"2008","journal-title":"J Diabetes Sci. Technol."},{"key":"10.1016\/j.drudis.2018.11.010_bib0095","series-title":"FDA Approves Two New Drug Treatments for Diabetes Mellitus","author":"FDA","year":"2015"},{"key":"10.1016\/j.drudis.2018.11.010_bib0100","series-title":"EMEA-000456-PIP01-08-M02","author":"EMA","year":"2014"},{"key":"10.1016\/j.drudis.2018.11.010_bib0105","series-title":"Fiasp Insulin Aspart","author":"EMA","year":"2017"},{"key":"10.1016\/j.drudis.2018.11.010_bib0110","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/dom.12468","article-title":"Faster-acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart","volume":"17","author":"Heise","year":"2015","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.drudis.2018.11.010_bib0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/157339913804143225","article-title":"Regulation of insulin synthesis and secretion and pancreatic beta-cell dysfunction in diabetes","volume":"9","author":"Fu","year":"2013","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.drudis.2018.11.010_bib0120","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.2147\/DDDT.S79322","article-title":"Insulin administration: present strategies and future directions for a noninvasive (possibly more physiological) delivery","volume":"9","author":"Matteucci","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.drudis.2018.11.010_bib0125","doi-asserted-by":"crossref","first-page":"16290","DOI":"10.1074\/jbc.M114.562355","article-title":"Inefficient translocation of preproinsulin contributes to pancreatic beta cell failure and late-onset diabetes","volume":"289","author":"Guo","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2018.11.010_bib0130","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/jn\/136.4.873","article-title":"Regulation of the insulin gene by glucose and fatty acids","volume":"136","author":"Poitout","year":"2006","journal-title":"J. Nutr."},{"key":"10.1016\/j.drudis.2018.11.010_bib0135","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1083\/jcb.121.6.1211","article-title":"Discrete nascent chain lengths are required for the insertion of presecretory proteins into microsomal membranes","volume":"121","author":"Wolin","year":"1993","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.drudis.2018.11.010_bib0140","doi-asserted-by":"crossref","first-page":"11476","DOI":"10.1016\/S0021-9258(19)49934-1","article-title":"Translocation of preproinsulin across the endoplasmic reticulum membrane: The relationship between nascent polypeptide size and extent of signal recognition particle-mediated inhibition of protein synthesis","volume":"267","author":"Okun","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2018.11.010_bib0145","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1073\/pnas.75.3.1260","article-title":"Detection and kinetic behavior of preproinsulin in pancreatic islets","volume":"75","author":"Patzelt","year":"1978","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2018.11.010_bib0150","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1073\/pnas.73.6.1964","article-title":"Cell-free synthesis of rat preproinsulins: characterization and partial amino acid sequence determination","volume":"73","author":"Chan","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2018.11.010_bib0155","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1083\/jcb.108.4.1245","article-title":"Calcium and GTP: essential components in vesicular trafficking between the endoplasmic reticulum and Golgi apparatus","volume":"108","author":"Beckers","year":"1989","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.drudis.2018.11.010_bib0160","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10534-005-3685-y","article-title":"Zinc\u2013ligand interactions modulate assembly and stability of the insulin hexamer\u2014a review","volume":"18","author":"Dunn","year":"2005","journal-title":"Biometals"},{"key":"10.1016\/j.drudis.2018.11.010_bib0165","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1055\/s-2007-1001766","article-title":"Improving insulin therapy: achievements and challenges","volume":"26","author":"Galloway","year":"1994","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.drudis.2018.11.010_bib0170","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2165\/11584360-000000000-00000","article-title":"A review of 25 years\u2019 experience with the NovoPen\u00ae family of insulin pens in the management of diabetes mellitus","volume":"30","author":"Hyllested-Winge","year":"2010","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.drudis.2018.11.010_bib0175","series-title":"British National Formulary 72","first-page":"640","article-title":"Endocrine system","author":"BNF","year":"2016"},{"key":"10.1016\/j.drudis.2018.11.010_bib0180","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/dia.2010.0016","article-title":"Insulin patch pumps: their development and future in closed-loop systems","volume":"12","author":"Anhalt","year":"2010","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.drudis.2018.11.010_bib0185","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s13300-010-0004-6","article-title":"The OmniPod Insulin Management System: the latest innovation in insulin pump therapy","volume":"1","author":"Zisser","year":"2010","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.drudis.2018.11.010_bib0190","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1177\/1932296815580361","article-title":"V-Go insulin delivery system versus multiple daily insulin injections for patients with uncontrolled type 2 diabetes mellitus","volume":"9","author":"Winter","year":"2015","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.drudis.2018.11.010_bib0195","doi-asserted-by":"crossref","first-page":"30","DOI":"10.17925\/USE.2007.00.2.30","article-title":"V-Go\u2122\u2014a novel device for delivering basal\u2013bolus insulin therapy to patients with type 2 diabetes mellitus","volume":"2007","author":"Gilbert","year":"2007","journal-title":"US Endocrinol."},{"key":"10.1016\/j.drudis.2018.11.010_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jps.2600810102","article-title":"Drug delivery via the mucous membranes of the oral cavity","volume":"81","author":"Harris","year":"1992","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2018.11.010_bib0205","first-page":"15","article-title":"Buccal mucosa as a route for systemic drug delivery: a review","volume":"1","author":"Shojaei","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2018.11.010_bib0210","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1600-0846.2008.00316.x","article-title":"Delivering drugs by the transdermal route: review and comment","volume":"14","author":"Tanner","year":"2008","journal-title":"Skin Res. Technol."},{"key":"10.1016\/j.drudis.2018.11.010_bib0215","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/193229680900300323","article-title":"Oral insulin and buccal insulin: a critical reappraisal","volume":"3","author":"Heinemann","year":"2009","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.drudis.2018.11.010_bib0220","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.nut.2009.08.001","article-title":"Inhaled insulin\u2014intrapulmonary, intranasal, and other routes of administration: mechanisms of action","volume":"26","author":"Henkin","year":"2010","journal-title":"Nutrition"},{"key":"10.1016\/j.drudis.2018.11.010_bib0225","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/1932296814530060","article-title":"Intradermal insulin delivery: a promising future for diabetes management","volume":"8","author":"Hultstrom","year":"2014","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.drudis.2018.11.010_bib0230","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.clinthera.2014.06.025","article-title":"Inhaled insulin: a breath of fresh air? A review of inhaled insulin","volume":"36","author":"Cavaiola","year":"2014","journal-title":"Clin. Ther."},{"key":"10.1016\/j.drudis.2018.11.010_bib0235","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ijpharm.2015.08.038","article-title":"Mucoadhesive oral films: the potential for unmet needs","volume":"494","author":"Silva","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2018.11.010_bib0240","series-title":"Oral Mucosal Drug Delivery and Therapy. Advances in Delivery Science and Technology","first-page":"17","article-title":"Overview of oral mucosal delivery","author":"Rathbone","year":"2015"},{"key":"10.1016\/j.drudis.2018.11.010_bib0245","series-title":"AFREZZA\u00ae (Insulin Human) Inhalation Powder","author":"FDA","year":"2014"},{"key":"10.1016\/j.drudis.2018.11.010_bib0250","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1007\/s11095-017-2215-2","article-title":"Good things in small packages: an innovative delivery approach for inhaled insulin","volume":"34","author":"Fink","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.drudis.2018.11.010_bib0255","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.2337\/diacare.26.10.2842","article-title":"Dose-response relationships of inhaled insulin delivered via the Aerodose insulin inhaler and subcutaneously injected insulin in patients with type 2 diabetes","volume":"26","author":"Kim","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.drudis.2018.11.010_bib0260","series-title":"Initiation of Phase IIa Study of Insulin Delivery via Buccal Strip for Type 1 Diabetes","author":"Midatech Pharma","year":"2015"},{"key":"10.1016\/j.drudis.2018.11.010_bib0265","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1208\/s12248-017-0054-z","article-title":"Challenges and future prospects for the delivery of biologics: oral mucosal, pulmonary, and transdermal routes","volume":"19","author":"Morales","year":"2017","journal-title":"AAPS J."},{"key":"10.1016\/j.drudis.2018.11.010_bib0270","series-title":"Midatech\u2019s Primary Platform Technology Is Based on Carbohydrate-Coated Gold Nanoparticle (GNP) Drug Conjugates","author":"Midatech Pharma","year":"2017"},{"key":"10.1016\/j.drudis.2018.11.010_bib0275","series-title":"Midatech Pharma Announces Clinical Pipeline Update","author":"Midatech Pharma","year":"2016"},{"key":"10.1016\/j.drudis.2018.11.010_bib0280","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/193229681300700228","article-title":"Oral insulin delivery: how far are we?","volume":"7","author":"Fonte","year":"2013","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.drudis.2018.11.010_bib0285","series-title":"Company Announcement: Financial Report for the Period 1 January 2015 to 30 June 2015","author":"Novo Nordisk","year":"2015"},{"key":"10.1016\/j.drudis.2018.11.010_bib0290","series-title":"Technology","author":"Oramed Pharmaceuticals","year":"2016"},{"key":"10.1016\/j.drudis.2018.11.010_bib0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059524","article-title":"Glucose-reducing effect of the ORMD-0801 oral insulin preparation in patients with uncontrolled type 1 diabetes: A Pilot Study","volume":"8","author":"Eldor","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2018.11.010_bib0300","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1177\/193229680900300627","article-title":"Hepatic-directed vesicle insulin: a review of formulation development and preclinical evaluation","volume":"3","author":"Geho","year":"2009","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.drudis.2018.11.010_bib0305","series-title":"Delivering Medical Breakthroughs for Diabetes & Obesity: Pipeline","author":"Diasome Pharmaceuticals","year":"2016"},{"key":"10.1016\/j.drudis.2018.11.010_bib0310","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1463-1326.2009.01146.x","article-title":"The glucose lowering effect of an oral insulin (Capsulin) during an isoglycaemic clamp study in persons with type 2 diabetes","volume":"12","author":"Luzio","year":"2010","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.drudis.2018.11.010_bib0315","unstructured":"Gribova, O. and Vol, A. Oshadi Drug Administration. Methods and compositions for oral administration of insulin. WO 20100278922"},{"key":"10.1016\/j.drudis.2018.11.010_bib0320","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1177\/1932296814529988","article-title":"Oral insulin reloaded: a structured approach","volume":"8","author":"Zijlstra","year":"2014","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.drudis.2018.11.010_bib0325","series-title":"Active Discovery Programs","author":"Biocon","year":"2016"},{"key":"10.1016\/j.drudis.2018.11.010_bib0330","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1463-1326.2010.01213.x","article-title":"A dose range finding study of novel oral insulin (IN-105) under fed conditions in type 2 diabetes mellitus subjects","volume":"12","author":"Khedkar","year":"2010","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.drudis.2018.11.010_bib0335","series-title":"Capsulin","author":"Diabetology","year":"2017"},{"key":"10.1016\/j.drudis.2018.11.010_bib0340","series-title":"Axcess Oral Delivery System","author":"Diabetology","year":"2017"},{"key":"10.1016\/j.drudis.2018.11.010_bib0345","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jsps.2014.06.004","article-title":"A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives","volume":"24","author":"Muheem","year":"2016","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.drudis.2018.11.010_bib0350","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0169-409X(92)90015-I","article-title":"(C) Means to enhance penetration: (2) Intestinal permeability enhancement for proteins, peptides and other polar drugs: mechanisms and potential toxicity","volume":"8","author":"Swenson","year":"1992","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.drudis.2018.11.010_bib0355","series-title":"Permeation Enhancement Technology","author":"CPEX Pharmaceuticals","year":"2011"},{"key":"10.1016\/j.drudis.2018.11.010_bib0360","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/193229681100500116","article-title":"Enhanced absorption of Nasulin\u2122, an ultrarapid-acting intranasal insulin formulation, using single nostril administration in normal subjects","volume":"5","author":"Stote","year":"2011","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.drudis.2018.11.010_bib0365","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1177\/193229680800200613","article-title":"Pharmacokinetics and pharmacodynamics of intranasal insulin spray (Nasulin\u2122) administered to healthy male volunteers: influence of the nasal cycle","volume":"2","author":"Leary","year":"2008","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.drudis.2018.11.010_bib0370","first-page":"553","article-title":"Use of insulin in diabetes: a century of treatment","volume":"21","author":"Shahani","year":"2015","journal-title":"Hong Kong Med. J."},{"key":"10.1016\/j.drudis.2018.11.010_bib0375","first-page":"22","article-title":"Designing an ultrasound enabled patch for insulin","volume":"49","author":"Redding","year":"2014","journal-title":"ONdrugDelivery"},{"key":"10.1016\/j.drudis.2018.11.010_bib0380","series-title":"Insulin Inhaled","author":"Specialist Pharamcy Service","year":"2016"},{"key":"10.1016\/j.drudis.2018.11.010_bib0385","first-page":"735","article-title":"Afrezza (Insulin Human) inhalation powder: a new inhaled insulin for the management of type-1 or type-2 diabetes mellitus","volume":"40","author":"Goldberg","year":"2015","journal-title":"P.T."},{"key":"10.1016\/j.drudis.2018.11.010_bib0390","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s40265-015-0472-0","article-title":"AFREZZA\u00ae (insulin human) inhalation powder: a review in diabetes mellitus","volume":"75","author":"Kim","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.drudis.2018.11.010_bib0395","doi-asserted-by":"crossref","first-page":"4568903","DOI":"10.1155\/2018\/4568903","article-title":"Rethinking the viability and utility of inhaled insulin in clinical practice","volume":"2018","author":"Heinemann","year":"2018","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.drudis.2018.11.010_bib0400","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/2327-6924.12247","article-title":"Afrezza: an inhaled approach to insulin delivery","volume":"27","author":"Fleming","year":"2015","journal-title":"J. Am. Assoc. Nurse Pract."},{"key":"10.1016\/j.drudis.2018.11.010_bib0405","series-title":"Humalog 100 Units\/ml KwikPen, Solution for Injection in a Pre-Filled Pen","author":"EMC","year":"2018"},{"key":"10.1016\/j.drudis.2018.11.010_bib0410","series-title":"Insulin Buccal","author":"Specialist Pharmacy Service","year":"2018"},{"key":"10.1016\/j.drudis.2018.11.010_bib0415","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.reactfunctpolym.2010.10.002","article-title":"Oral protein delivery: current status and future prospect","volume":"71","author":"Park","year":"2011","journal-title":"React. Funct. Polym."},{"key":"10.1016\/j.drudis.2018.11.010_bib0420","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1517\/17425247.5.9.1047","article-title":"Delivery of insulin to the buccal mucosa utilizing the RapidMist\u2122 system","volume":"5","author":"Bernstein","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.drudis.2018.11.010_bib0425","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1002\/dmrr.208","article-title":"The evolving role of oral insulin in the treatment of diabetes using a novel RapidMist\u2122 system","volume":"18","author":"Modi","year":"2002","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.drudis.2018.11.010_bib0430","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1463-1326.2009.01127.x","article-title":"Review of clinical trials: update on oral insulin spray formulation","volume":"12","author":"Pozzilli","year":"2009","journal-title":"Diabetes Obes. Metab."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135964461830254X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135964461830254X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:37:52Z","timestamp":1761223072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135964461830254X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":86,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S135964461830254X"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2018.11.010","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of non-invasive insulin delivery systems for diabetes therapy in clinical trials over the past decade","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2018.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}